Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 605.50
-14.50 (-2.34%)
Aug 14, 2026, 4:17 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 41.17 million as of August 14, 2026. Its market cap has increased by 532.30% in one year.
Market Cap
41.17M
Enterprise Value
41.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
605.50
ChartMarket Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 41.17M, an increase of 285.48%. That is a compound annual growth rate of 16.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 41.17M | 19.15% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 91.98M |
| 4basebio | 85.46M |
| Bioventix | 78.37M |
| Ondine Biomedical | 71.44M |
| Poolbeg Pharma | 66.42M |
| hVIVO | 45.00M |
| Sareum Holdings | 36.72M |
| ImmuPharma | 27.39M |